Bioequivalence - Duodart Against Avodart & Omnic

NCT01657851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: dutasteride/tamsulosin
DRUG: dutasteride
DRUG: tamsulosin

Sponsor

GlaxoSmithKline